|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
|
AU759641B2
(en)
|
1998-08-19 |
2003-04-17 |
Skyepharma Canada Inc. |
Injectable aqueous dispersions of propofol
|
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
|
CA2479665C
(en)
*
|
2002-03-20 |
2011-08-30 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
US20080220075A1
(en)
*
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
CA2503956A1
(en)
*
|
2002-10-29 |
2004-05-13 |
Transform Pharmaceuticals, Inc. |
Propofol with cysteine
|
|
SI1585548T1
(sl)
|
2002-12-09 |
2018-11-30 |
Abraxis Bioscience, Llc |
Sestave in metode odmerjanja farmakoloških sredstev
|
|
US7468394B1
(en)
*
|
2003-03-11 |
2008-12-23 |
Amphastar Pharmaceuticals, Inc. |
Sterile pharmaceutical composition and process for a solution of propofol emulsion having microbial growth retardation
|
|
US20040225022A1
(en)
*
|
2003-05-09 |
2004-11-11 |
Desai Neil P. |
Propofol formulation containing reduced oil and surfactants
|
|
US8476010B2
(en)
*
|
2003-07-10 |
2013-07-02 |
App Pharmaceuticals Llc |
Propofol formulations with non-reactive container closures
|
|
US8546453B2
(en)
*
|
2003-08-14 |
2013-10-01 |
Rensheng Zhang |
Propofol compositions and methods for reducing pain associated with propofol injection
|
|
RU2290169C1
(ru)
*
|
2005-06-23 |
2006-12-27 |
Открытое Акционерное Общество "Фаберлик" |
Косметическое и/или дерматологическое средство и антиоксидант
|
|
RU2433818C2
(ru)
|
2005-08-31 |
2011-11-20 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи |
Композиции, включающие слаборастворимые в воде фармацевтические вещества и противомикробные вещества
|
|
NZ592132A
(en)
*
|
2005-08-31 |
2012-12-21 |
Abraxis Bioscience Llc |
Composition comprising nanoparticles of docitaxel and a citrate
|
|
CN101411685B
(zh)
*
|
2007-10-19 |
2011-04-20 |
上海医药工业研究院 |
一种静脉麻醉药2,6-二异丙基苯酚微乳组合物及其制备方法
|
|
MX2012010684A
(es)
|
2010-03-17 |
2012-11-06 |
Novaliq Gmbh |
Composicion farmaceutica para el tratamiento de la presion intraocular incrementada.
|
|
EP2444063A1
(en)
|
2010-10-20 |
2012-04-25 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the delivery of active ingredients
|
|
EP2462921A1
(en)
|
2010-11-11 |
2012-06-13 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the treatment of a posterior eye disease
|
|
EP3202421B1
(en)
*
|
2011-01-04 |
2018-03-28 |
Novaliq GmbH |
O/w-emulsions comprising semifluorinated alkanes
|
|
CN107088226A
(zh)
*
|
2011-03-04 |
2017-08-25 |
格吕伦塔尔有限公司 |
他喷他多的胃肠外给药
|
|
HUE046557T2
(hu)
|
2011-03-04 |
2020-03-30 |
Gruenenthal Gmbh |
Tapentadolt tartalmazó vizes gyógyszerészeti készítmény szájon át alkalmazásra
|
|
JP2019142972A
(ja)
*
|
2011-03-04 |
2019-08-29 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
タペンタドールの非経口的投与
|
|
WO2012119729A1
(en)
|
2011-03-04 |
2012-09-13 |
Grünenthal GmbH |
Semisolid aqueous pharmaceutical composition containing tapentadol
|
|
CA2834855C
(en)
|
2011-05-25 |
2020-12-29 |
Novaliq Gmbh |
Topical pharmaceutical composition based on semifluorinated alkanes
|
|
JP2013001700A
(ja)
*
|
2011-06-21 |
2013-01-07 |
Fujifilm Corp |
プロポフォール含有水中油型エマルション組成物
|
|
JP5759804B2
(ja)
*
|
2011-06-27 |
2015-08-05 |
富士フイルム株式会社 |
容器詰製剤
|
|
PL2806886T3
(pl)
|
2012-01-23 |
2017-08-31 |
Novaliq Gmbh |
Stabilizowane kompozycje białkowe oparte na semifluorowanych alkanach
|
|
MX374014B
(es)
|
2012-05-16 |
2020-07-24 |
Mewa Singh |
Composiciones farmaceuticas para la entrega de farmacos insolubles en agua.
|
|
CN113694048B
(zh)
|
2012-09-12 |
2023-03-24 |
诺瓦利克有限责任公司 |
包含半氟化烷烃的混合物的组合物
|
|
MX350588B
(es)
|
2012-09-12 |
2017-09-11 |
Novaliq Gmbh |
Composiciones de alcanos semifluorados.
|
|
DK3024484T3
(en)
|
2013-07-23 |
2018-10-08 |
Novaliq Gmbh |
STABILIZED ANTIBODY COMPOSITIONS
|
|
WO2016156147A1
(en)
|
2015-03-27 |
2016-10-06 |
Grünenthal GmbH |
Stable formulation for parenteral administration of tapentadol
|
|
WO2017017693A1
(en)
*
|
2015-07-24 |
2017-02-02 |
Neon Laboratories Limited |
Stabilized injectable emulsion of propofol and ketamine
|
|
US11622937B2
(en)
|
2015-08-20 |
2023-04-11 |
Mewa Singh |
Polyphenolic polymer to make water-insoluble molecules become water-soluble
|
|
CN120884568A
(zh)
|
2015-09-30 |
2025-11-04 |
诺瓦利克有限责任公司 |
半氟化化合物和其组合物
|
|
PL3356313T3
(pl)
|
2015-09-30 |
2020-11-16 |
Novaliq Gmbh |
2-perfluoroheksylooktan do podawania okulistycznego
|
|
USRE50060E1
(en)
|
2016-06-23 |
2024-07-30 |
Novaliq Gmbh |
Topical administration method
|
|
ES2969758T3
(es)
|
2016-09-22 |
2024-05-22 |
Novaliq Gmbh |
Composiciones farmacéuticas para usar en la terapia de la blefaritis
|
|
AU2017329964B2
(en)
|
2016-09-23 |
2022-10-06 |
Grünenthal GmbH |
Stable formulation for parenteral administration of Tapentadol
|
|
CN109906085B
(zh)
|
2016-09-23 |
2024-03-08 |
诺瓦利克有限责任公司 |
含有环孢素的眼用组合物
|
|
EP3612228B1
(en)
|
2017-04-21 |
2023-08-23 |
Dermaliq Therapeutics, Inc. |
Iodine compositions
|
|
CN110650734B
(zh)
|
2017-05-12 |
2024-11-15 |
诺瓦利克有限责任公司 |
治疗与隐形眼镜有关病症的包含半氟化烷烃的药物组合物
|
|
CA3076776A1
(en)
|
2017-09-27 |
2019-04-04 |
Novaliq Gmbh |
Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
|
|
US11896559B2
(en)
|
2017-10-04 |
2024-02-13 |
Novaliq Gmbh |
Opthalmic compositions comprising F6H8
|
|
AU2019228119A1
(en)
|
2018-03-02 |
2020-09-10 |
Novaliq Gmbh |
Pharmaceutical compositions comprising nebivolol
|
|
CN112153970A
(zh)
|
2018-04-27 |
2020-12-29 |
诺瓦利克有限责任公司 |
用于治疗青光眼的包含他氟前列素的眼用组合物
|
|
AU2019358249B2
(en)
|
2018-10-12 |
2024-02-22 |
Novaliq Gmbh |
Ophthalmic composition for treatment of dry eye disease
|
|
US12397039B2
(en)
|
2019-02-13 |
2025-08-26 |
Novaliq Gmbh |
Compositions and methods for the treatment of ocular neovascularization
|